ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2019, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2019-01-09
DOI
10.1155/2019/1802620
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma
- (2018) Ruichao Chai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Endothelial trans-differentiation in glioblastoma recurring after radiotherapy
- (2018) Ivana De Pascalis et al. MODERN PATHOLOGY
- Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas
- (2018) Rui-Chao Chai et al. CNS Neuroscience & Therapeutics
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Prognostic Relevance of Tumor Purity and Interaction with MGMT Methylation in Glioblastoma
- (2017) Eva Schulze Heuling et al. MOLECULAR CANCER RESEARCH
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women
- (2017) Latha Kadalayil et al. Nature Communications
- Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas
- (2017) Zheng Zhao et al. Scientific Data
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- CGCG clinical practice guidelines for the management of adult diffuse gliomas
- (2016) Tao Jiang et al. CANCER LETTERS
- Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma
- (2016) Noelyn A Hung et al. MODERN PATHOLOGY
- A founder mutation in ADAMTSL4 causes early-onset bilateral ectopia lentis among Jews of Bukharian origin
- (2016) Eyal Reinstein et al. MOLECULAR GENETICS AND METABOLISM
- Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma
- (2016) Zheng Wang et al. OncoImmunology
- Biomarkers for glioma immunotherapy: the next generation
- (2015) Jennifer S. Sims et al. JOURNAL OF NEURO-ONCOLOGY
- ADAMTS proteins as modulators of microfibril formation and function
- (2015) Dirk Hubmacher et al. MATRIX BIOLOGY
- Circulating biomarkers for gliomas
- (2015) Manfred Westphal et al. Nature Reviews Neurology
- Human cerebral organoids recapitulate gene expression programs of fetal neocortex development
- (2015) J. Gray Camp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic pan-cancer analysis of tumour purity
- (2015) Dvir Aran et al. Nature Communications
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) R. Stupp et al. ANNALS OF ONCOLOGY
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Orchestrating immune check-point blockade for cancer immunotherapy in combinations
- (2014) Jose Luis Perez-Gracia et al. CURRENT OPINION IN IMMUNOLOGY
- Hedgehog Pathway Inhibition in Chondrosarcoma Using the Smoothened Inhibitor IPI-926 Directly Inhibits Sarcoma Cell Growth
- (2014) V. T. Campbell et al. MOLECULAR CANCER THERAPEUTICS
- Immunotherapy advances for glioblastoma
- (2014) D. A. Reardon et al. NEURO-ONCOLOGY
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
- (2014) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- Ectopia lentis et pupillae in four generations caused by novel mutations in theADAMTSL4gene
- (2013) Yassi Sharifi et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
- (2013) O. Bloch et al. CLINICAL CANCER RESEARCH
- Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution
- (2013) Sandra H E Boots-Sprenger et al. MODERN PATHOLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Role of ADAMTSL4 mutations in FBN1 mutation-negative ectopia lentis patients
- (2010) Jose Antonio Aragon-Martin et al. HUMAN MUTATION
- Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
- (2009) L. A.M. Gravendeel et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation